Brief: Galera Therapeutics reports Q2 results
09/08/2022 12:51
Aug 9 (Reuters) - Galera Therapeutics Inc GRTX.O :
* GALERA REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND
RECENT
CORPORATE UPDATES
* Q2 LOSS PER SHARE $0.54
Source text for Eikon: ID:nGNXMRQf3
Further company coverage: GRTX.O
Recent news on Galera Therapeutics
See all newsBrief: Galera Therapeutics Says Nasdaq Will Delist Co's Common Stock By Filing Form 25 With SEC On Sept 4
Brief: Galera Announces Board Approval Of Complete Liquidation And Dissolution
Brief: Galera Therapeutics Receives Written Notice From Nasdaq Indicating That Nasdaq Hearings Panel Determined To Delist Co’s Shares
Brief: Alpha Pharma Investments Llc Reports 10.899% Passive Stake In Galera Therapeutics
Brief: Galera Adopts Limited Duration Stockholder Rights Agreement